Accuray (ARAY) Cash from Investing Activities (2010 - 2026)
Accuray (ARAY) posted quarterly Cash from Investing Activities of -$1.5 million for Q1 2026, up 70.59% year-over-year from -$882809.8 in Q1 2025, and up 73.09% quarter-over-quarter from -$5.6 million in Q4 2025.
Accuray (ARAY) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Accuray's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$1.5 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 70.59% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at -$16.0 million (down 46.59% YoY), while the FY2025 annual figure was -$8.5 million, down 136.68% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$1.5 million, up from -$5.6 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$1.1 million in Q3 2023, with the low at -$5.6 million in Q4 2025.
- The 5-year median for Cash from Investing Activities is -$1.6 million (2024), against an average of -$2.7 million.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities sank 256.43% in 2025, then jumped 70.59% in 2026.
- Accuray's Cash from Investing Activities stood at -$1.5 million in 2022, then advanced by 18.58% to -$1.2 million in 2023, then decreased by 25.7% to -$1.6 million in 2024, then tumbled by 256.43% to -$5.6 million in 2025, then jumped by 73.09% to -$1.5 million in 2026.
- Business Quant data shows ARAY's Cash from Investing Activities at -$1.5 million in Q1 2026, -$5.6 million in Q4 2025, and -$3.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Accuray | 37.50 Mn | -2.20 Mn | 25.29 Mn | -1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.51 Mn |
| Mar 31, 2026 | -1.51 Mn |
| Dec 31, 2025 | -5.60 Mn |
| Dec 31, 2025 | -5.60 Mn |
| Sep 30, 2025 | -3.82 Mn |
| Sep 30, 2025 | -3.82 Mn |
| Mar 31, 2025 | -5.12 Mn |
| Mar 31, 2025 | -5.12 Mn |
| Dec 31, 2024 | -1.57 Mn |
| Dec 31, 2024 | -1.57 Mn |
| Sep 30, 2024 | -1.12 Mn |
| Sep 30, 2024 | -1.12 Mn |
| Mar 31, 2024 | -3.14 Mn |
| Mar 31, 2024 | -3.14 Mn |
| Dec 31, 2023 | -1.25 Mn |
| Dec 31, 2023 | -1.25 Mn |
| Sep 30, 2023 | -1.09 Mn |
| Sep 30, 2023 | -1.09 Mn |
| Mar 31, 2023 | -4.71 Mn |
| Mar 31, 2023 | -4.71 Mn |